Loading...
NPI 1588048714 · Concord, NC · Community/Retail Pharmacy
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Truecarerx, LLC is a community/retail pharmacy provider located in Concord, North Carolina. This profile covers 10 Medicare and 15 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Truecarerx, LLC |
| Address | 760 Cabarrus Ave W |
| City | Concord |
| State | NC |
| ZIP | 28027 |
| Taxonomy | Community/Retail Pharmacy |
| NPI Enumerated | July 17, 2015 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $183.3K |
| Medicare | $116.1K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
10 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 5,260 | $10 | $63.1K |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 230 | $80 | $17.8K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 80 | $130 | $10.2K |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 60 | $140 | $9.2K |
| G0008 | Administration of influenza virus vaccine | 270 | $30 | $7.9K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 150 | $40 | $5.7K |
| 90674 | This code represents a flu vaccine product that protects against four strains of influenza. It is derived from cell cultures, contains no preservatives or antibiotics, and is administered as a 0.5 mL… | 40 | $30 | $1.3K |
| 0124A | N/A | 30 | $40 | $1K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 10 | $50 | $600 |
| 0134A | N/A | 10 | $40 | $510 |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 10 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
15 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| A4554 | Disposable underpads, all sizes | 1,890 | $50 | $92.7K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1,160 | $30 | $36K |
| T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | 190 | $110 | $21.4K |
| E0570 | Nebulizer, with compressor | 180 | $110 | $19.1K |
| 87428 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient specimen for antigens of severe acute respiratory syndrome (SARS) coronavirus, such as SARS–CoV–2… | 240 | $40 | $8.7K |
| 0013A | N/A | 30 | $60 | $1.8K |
| 0011A | N/A | 20 | $60 | $1K |
| 0012A | N/A | 20 | $60 | $980 |
| 90674 | This code represents a flu vaccine product that protects against four strains of influenza. It is derived from cell cultures, contains no preservatives or antibiotics, and is administered as a 0.5 mL… | 30 | $30 | $780 |
| 90471 | In this procedure, the provider administers a live attenuated vaccine using a percutaneous, intradermal, subcutaneous, or intramuscular route. | 40 | $10 | $380 |
Showing 1–10 of 15
How this provider's Medicaid billing volume and revenue compare to other North Carolina providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. North Carolina median
15 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | 93 | 130 | 610 | $110 | $637.1K |
| A4554 | Disposable underpads, all sizes | 83 | 200 | 1,300 | $40 | $493.2K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 32 | 100 | 550 | $50 | $153.4K |
| E0570 | Nebulizer, with compressor | 148 | 210 | 760 | $30 | $82.6K |
| 87428 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient specimen for antigens of severe acute respiratory syndrome (SARS) coronavirus, such as SARS–CoV–2… | 112 | 210 | 310 | $50 | $73K |
| A4253 | Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips | 60 | 200 | 100 | $80 | $68.8K |
| 90471 | In this procedure, the provider administers a live attenuated vaccine using a percutaneous, intradermal, subcutaneous, or intramuscular route. | 1,144 | 1,570 | 160 | $20 | $45K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 99 | 110 | 40 | $30 | $4.1K |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 27 | 30 | 30 | $60 | $2.7K |
| 0012A | N/A | 407 | 500 | 40 | $40 | $2.7K |
Showing 1–10 of 15
Other providers in the same ZIP code as Truecarerx, LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Hometown Oxygen Charlotte LLC | NC | Oxygen Equipment & Supplies (DME) | $0 | $83.8M |
| Independent Opportunities, Inc | NC | Community/Behavioral Health Agency | $0 | $22.1M |
| Mmi Holdings LLC | NC | Durable Medical Equipment & Medical Supplies | $0 | $8.3M |
| Mpv Enterprises, LLC | NC | Assisted Living Facility | $0 | $7.7M |
| Secure Direction Nc, LLC. | NC | Community/Behavioral Health Agency | $0 | $7.2M |
| County Of Cabarrus Office Of Treasurer | NC | Land Ambulance | $1.7M | $5.1M |
| Swathi Gopala | NC | Physical Therapist | $141.7K | $0 |
| Emily Womble | NC | Physician Assistant | $49.7K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.